(W2O Group) Yumanity Therapeutics, a company focused on discovering transformative therapies to treat neurodegenerative diseases, today announced the publication of study results describing a potential new target for therapeutic intervention in Parkinson's disease and other related disorders.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2rlkNlD
No comments:
Post a Comment